Presentation TCT 2022 TCT 733: "Collateral" Damage: Uncovering the Etiology of Chest Pain Presenter: Tushar Ramesh September 17, 2022
Presentation TCT 2022 TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study Presenter: Daniel Burkhoff September 17, 2022
Presentation TCT 2022 TCT 69: Impella use for fulminant myocarditis in cardiogenic shock: Analysis of the Japan Registry for Percutaneous Ventricular Assist Device (J-PVAD) Presenter: Koichi Toda September 17, 2022
Presentation TCT 2022 TCT 38: Impact of Smoking on Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention Presenter: Marta Bujak September 17, 2022
Presentation TCT 2022 First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation Presenter: David Adams September 17, 2022
Presentation TCT 2022 Cerebral Embolic Protection: Why, When, and Who? Presenter: Axel Linke September 17, 2022
Presentation TCT 2022 Expanding the Boundaries of MR Treatments with Early Results from the SUMMIT Trial Presenter: Gorav Ailawadi September 17, 2022
Presentation TCT 2022 Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB) Presenter: Bernardo Cortese September 17, 2022
Presentation TCT 2022 TCT 210: Long-term blood pressure results after renal sympathetic denervation using endovascular ultrasound Presenter: Karl Fengler September 17, 2022
Presentation TCT 2022 TCT 65: Pulmonary Artery Catheter Use is Associated with Lower Mortality in Cardiogenic Shock, Especially among Patients with Heart Failure Presenter: Navin Kapur September 17, 2022
Presentation TCT 2022 TCT 37: Impact of Right Ventricular Failure on The Outcomes of Acute Inferior Wall Myocardial Infarction Presenter: Antony Anandaraj September 17, 2022
Presentation TCT 2022 TCT 700: Percutaneous Management of Iatrogenic VSD following TAVR: Uncommon Complication of TAVR Presenter: Seun Alli September 17, 2022
Presentation TCT 2022 TCT 758: Low Contrast Protected PCI Combining DES and DEB for the Treatment of Severely Calcified Left Main and Multivessel Disease in a High-Risk Patient Presenter: Ottavia Cozzi September 17, 2022
Presentation TCT 2022 DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB Presenter: Paul Underwood September 17, 2022
Presentation TCT 2022 TCT 682: Ultra-Low Contrast Unprotected Left Main Percutaneous Coronary Intervention Using Intravascular Ultrasound and Sepal Technique Presenter: Bryan Rene Toledano September 17, 2022
Presentation TCT 2022 Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier? Presenter: Philippe Genereux September 17, 2022
Presentation TCT 2022 Case #2: MVD With Low Ejection Fraction (High-Risk for CABG) Presenter: Arnold Seto September 17, 2022
Presentation TCT 2022 The Value of FEops HEARTguide™ Computational Modeling in the Planning of Percutaneous LAA Closure: The PREDICT LAA Trial Presenter: Ole De Backer September 17, 2022
Presentation TCT 2022 TCT 209: Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study Presenter: Sahil Parikh September 17, 2022
Presentation TCT 2022 TCT 68: Complete Revascularisation in Patients Presenting with ST-Elevation MI, Cardiogenic Shock and Multi-vessel Disease is Associated With Higher Mortality at 30 Days, 1 Year and up to 30 Months Follow-up Presenter: Alexander Tindale September 17, 2022